HIV-1 binding and neutralizing antibodies of injecting drug users.

about

HIV-1 binding and neutralizing antibodies of injecting drug users.

Item

http://www.wikidata.org/entity/Q45266508

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

HIV-1 binding and neutralizing antibodies of injecting drug users.

@en

HIV-1 binding and neutralizing antibodies of injecting drug users.

@nl

type

Item

label

HIV-1 binding and neutralizing antibodies of injecting drug users.

@en

HIV-1 binding and neutralizing antibodies of injecting drug users.

@nl

prefLabel

HIV-1 binding and neutralizing antibodies of injecting drug users.

@en

HIV-1 binding and neutralizing antibodies of injecting drug users.

@nl

P1476

HIV-1 binding and neutralizing antibodies of injecting drug users.

@en

P2093

C Silva-de-Jesus

http://www.w3.org/2001/XMLSchema#string

E P Ouverney

http://www.w3.org/2001/XMLSchema#string

F I Bastos

http://www.w3.org/2001/XMLSchema#string

M A Hacker

http://www.w3.org/2001/XMLSchema#string

M G Morgado

http://www.w3.org/2001/XMLSchema#string

S L M Teixeira

http://www.w3.org/2001/XMLSchema#string

V Bongertz

http://www.w3.org/2001/XMLSchema#string

P2860

Complete nucleotide sequence of the AIDS virus, HTLV-III

Antibody neutralization and escape by HIV-1

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.

Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.

Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil.

Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research Group.

HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.

Human immunodeficiency virus infection and infective endocarditis among injecting drug users.

P304

1313-1320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0100-879X2005000900004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16138213

http://www.w3.org/2001/XMLSchema#string